JP2001505910A5 - - Google Patents

Download PDF

Info

Publication number
JP2001505910A5
JP2001505910A5 JP1998526699A JP52669998A JP2001505910A5 JP 2001505910 A5 JP2001505910 A5 JP 2001505910A5 JP 1998526699 A JP1998526699 A JP 1998526699A JP 52669998 A JP52669998 A JP 52669998A JP 2001505910 A5 JP2001505910 A5 JP 2001505910A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1998526699A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001505910A (ja
Filing date
Publication date
Priority claimed from US08/806,584 external-priority patent/US5736151A/en
Application filed filed Critical
Publication of JP2001505910A publication Critical patent/JP2001505910A/ja
Publication of JP2001505910A5 publication Critical patent/JP2001505910A5/ja
Pending legal-status Critical Current

Links

JP52669998A 1996-12-09 1997-12-03 改良医薬組成物 Pending JP2001505910A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/806,584 US5736151A (en) 1996-12-09 1996-12-09 Antibiotic oil suspensions
US08/806,584 1996-12-09
PCT/US1997/021401 WO1998025621A1 (en) 1996-12-09 1997-12-03 Improved pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JP2001505910A JP2001505910A (ja) 2001-05-08
JP2001505910A5 true JP2001505910A5 (enExample) 2005-08-11

Family

ID=25194373

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52669998A Pending JP2001505910A (ja) 1996-12-09 1997-12-03 改良医薬組成物

Country Status (21)

Country Link
US (1) US5736151A (enExample)
EP (1) EP0941095B1 (enExample)
JP (1) JP2001505910A (enExample)
KR (1) KR100544248B1 (enExample)
CN (1) CN100413506C (enExample)
AT (1) ATE264681T1 (enExample)
AU (1) AU746666B2 (enExample)
BR (1) BR9714967B1 (enExample)
CA (1) CA2269682C (enExample)
CZ (1) CZ297632B6 (enExample)
DE (1) DE69728783T2 (enExample)
DK (1) DK0941095T3 (enExample)
ES (1) ES2218705T3 (enExample)
FI (1) FI991302L (enExample)
HU (1) HUP0000564A3 (enExample)
NO (1) NO325475B1 (enExample)
NZ (1) NZ336183A (enExample)
PL (1) PL190662B1 (enExample)
PT (1) PT941095E (enExample)
SK (1) SK72399A3 (enExample)
WO (1) WO1998025621A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60136367D1 (de) * 2000-09-12 2008-12-11 Pharmacia & Upjohn Co Llc Pharmazeutische zusammensetzung mit modifiziertem träger
US7829100B2 (en) * 2000-09-12 2010-11-09 Teagarden Dirk L Pharmaceutical composition having modified carrier
KR100423895B1 (ko) * 2001-02-19 2004-03-24 주식회사 엘지생명과학 셉티오퍼 하이드로클로라이드의 현탁제 조성물
US20040022815A1 (en) * 2002-08-05 2004-02-05 Orchid Health Care Novel pharmaceutical composition of ceftiofur
EP1528926A1 (en) * 2002-08-07 2005-05-11 Orchid Health Care Novel pharmaceutical composition of ceftiofur
KR20040015622A (ko) * 2002-08-13 2004-02-19 대한뉴팜(주) 세프티오푸르나트륨을 활성성분으로 함유하는 현탁주사액조성물
US7659061B2 (en) * 2002-11-19 2010-02-09 Pharmacia & Upjohn Company Pharmaceutical compositions having a modified vehicle
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US20040214753A1 (en) * 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
DE602004002201T2 (de) * 2003-03-20 2007-09-20 Pharmacia Corp. Dispergierbare pharmazeutische zusammensetzung eines entzündungshemmers
CA2529405A1 (en) * 2003-07-31 2005-02-03 Pharmacia & Upjohn Company Llc Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
WO2006008640A1 (en) * 2004-07-15 2006-01-26 Pharmacia & Upjohn Company Llc Non-aqueous suspension containing a drug having an unpleasant taste
CZ300424B6 (cs) * 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
CZ300590B6 (cs) * 2006-06-20 2009-06-24 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
AU2008215659B2 (en) 2007-02-16 2012-11-01 Aska Pharmaceutical Co., Ltd. Pharmaceutical composition comprising microparticle oily suspension
CN101406447B (zh) * 2007-10-12 2010-08-25 河南农业大学 复方头孢噻呋油混悬注射液制备工艺
US20100087481A1 (en) * 2008-10-03 2010-04-08 Lee Kathleen M Oral pharmaceutical formulations for antidiabetic compounds
BRPI0922041A8 (pt) * 2008-11-19 2022-08-16 Merial Ltd Formulações compreendendo ceftiofur e cetoprofeno ou cetiofur e álcool benzílico.
EP2874624B8 (en) 2012-07-17 2019-10-02 Bayer New Zealand Limited Injectable antibiotic formulations and their methods of use
FR3000392B1 (fr) 2012-12-27 2015-03-27 Virbac Nouvelles compositions pharmaceutiques veterinaires et leur procede de preparation
CN106456704A (zh) 2014-04-16 2017-02-22 Veyx-药物有限公司 兽药组合物和其应用
WO2016144862A1 (en) 2015-03-09 2016-09-15 Intekrin Therapeutics, Inc. Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
WO2018071810A1 (en) 2016-10-13 2018-04-19 RhinoNase, Inc. Antibiotic compositions for nasal irrigation and methods
KR20200036808A (ko) 2017-04-03 2020-04-07 코히러스 바이오사이언시스, 인크. 진행성 핵상 마비 치료를 위한 PPARγ 작용제
CN113209015A (zh) * 2020-01-21 2021-08-06 江西邦诚动物药业有限公司 长效盐酸头孢噻呋混悬注射液及其制备工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB914894A (en) * 1960-08-12 1963-01-09 Beecham Res Lab Injectable pharmaceutical media
NL120012C (enExample) * 1961-01-31
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
FR2479229B1 (fr) * 1980-03-26 1986-01-17 Clin Midy Nouveaux derives des cephalosporines, leur procede de preparation et les medicaments utilisables comme antibiotiques qui contiennent lesdits derives
US4902683A (en) * 1984-10-25 1990-02-20 The Upjohn Company Crystalline cephalosporin hydrohalide salts
US4937330A (en) * 1985-08-12 1990-06-26 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
EP0393066B1 (en) * 1987-11-10 1994-02-02 The Upjohn Company Cephalosporin antibiotics
US5223496A (en) * 1987-11-10 1993-06-29 The Upjohn Company Cephalosporin antibiotics
US4877782A (en) * 1988-02-16 1989-10-31 The Upjohn Company Zinc ceftiofur complexes
AU639004B2 (en) * 1989-06-13 1993-07-15 Abbott Laboratories Anhydrous oil-based liquid suspension for delivering a medicament
CZ289332B6 (cs) * 1993-03-12 2002-01-16 Pharmacia & Upjohn Company Krystalická volná kyselina ceftiofuru, způsob její přípravy a farmaceutický prostředek s jejím obsahem

Similar Documents

Publication Publication Date Title
JP2000506348A5 (enExample)
JP2001510603A5 (enExample)
JP2001517971A5 (enExample)
JP2001503517A5 (enExample)
JP2000506623A5 (enExample)
JP2001504398A5 (enExample)
JP2001508674A5 (enExample)
JP2001502151A5 (enExample)
JP2001502775A5 (enExample)
JP2000506747A5 (enExample)
JP2000508469A5 (enExample)
JP2000507544A5 (enExample)
JP2000506125A5 (enExample)
JP2001506386A5 (enExample)
JP2000510734A5 (enExample)
JP2000517074A5 (enExample)
JP2000517213A5 (enExample)
JP2000511540A5 (enExample)
JP2001505684A5 (enExample)
JP2001503620A5 (enExample)
JP2000508289A5 (enExample)
JP2000509128A5 (enExample)
JP2001501342A5 (enExample)
JP2000508067A5 (enExample)
JP2001506603A5 (enExample)